Business Wire

CONQUEST Group Announced the Expansion of its Asset Management Business with the Appointment of Philippe Taillardat to the Role of Director

Jaa

Philippe Taillardat brings to CONQUEST over 25 years of Asset Management and Investment Banking experience, primarily in principal investing, financial advisory, equity and debt financing across global infrastructure and sustainable energy sectors.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180316005030/en/

Philippe Taillardat (Photo: CONQUEST Group)

Philippe Taillardat (Photo: CONQUEST Group)

Philippe was most recently Co-Head of Infrastructure Investments Europe at First State Investments, which he helped transform into one of the leading billion+ European infrastructure fund manager in core / core+ strategies. Earlier in his career, Philippe held various senior banker and investment roles at Amundi, Credit Agricole CIB, Credit Suisse, AXA and BNP Paribas.

Frédéric Palanque, Managing Director of CONQUEST Group, said, "We are delighted to welcome such a recognized professional. CONQUEST is trusted for providing value-added advice in complex and highly confidential situations, bringing deep investment experience across industries, geographies, and various market cycles as well as our vast intellectual capital, unconventional thinking and problem solving approach. We believe Philippe, with his depth of experience in global infrastructure investments and institutional market coverage will bolster our current asset management capabilities and increasingly contribute to our unwavering commitment to putting client’s interest first to crystalize superior investment return. He will be an important addition to our European team and will be instrumental in growing both our existing and successor funds, which are custom-tailored to best benefit from the investors’ increasing awareness of climate change and sustainable infrastructure transformation trends.”

About CONQUEST Group

CONQUEST is an independent asset management and financial advisory firm with significant expertise in a broad range of international transactions and strategic situations. Institutional investors and corporate partners trust CONQUEST to provide thoughtful, customized strategies and solutions that help drive and deliver their core and long-term financial goals.
CONQUEST investment approach boils down to crafting transaction opportunities with long-term yielding objectives, less correlated and inflation linked, which implies Trust and alignment of interest with our investors and partners, earned thanks to common successful achievements.
With offices located in Dublin, Luxembourg, Paris and Hong Kong, and a partnership in India, the Firm has an expert team of 25 professionals, working seamlessly across geographies on our clients’ behalf.

For more information on CONQUEST Group, please got http://www.conquest.group

Important Information
This press release is intended for information only, aimed solely at the media and should not be further distributed to individual and/or corporate investors, and financial advisers and/or distributors. The information included within this document and any supplemental documentation provided should not be copied, reproduced or redistributed without the prior written consent of Conquest Group.

Contact information

CONQUEST Group
Zada Lau
Press enquiries: press@conquest.group

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Mundipharma Announces Launch of INVOKANA® and VOKANAMET® in Norway for the Treatment of Type 2 Diabetes as Part of Exclusive Distribution Agreement with Janssen20.3.2019 11:05:00 EETTiedote

The Mundipharma network of independent associated companies is pleased to launch the type-2 diabetes mellitus (T2DM) treatments Invokana ® (canagliflozin) and Vokanamet ® (canagliflozin, metformin) in Norway. In line with the partnership with Janssen Pharmaceutica NV, Mundipharma now exclusively distributes and markets these treatments across 18 countries in the European Economic Area (EEA) and Switzerland. With the launch in Norway, Invokana and Vokanamet are now available across the whole of Scandinavia, following the launches in Sweden and Denmark. Invokana, a once-daily oral tablet, is part of the sodium glucose co-transporter 2 (SGLT2) inhibitor class and has been approved in the European Union since 2013.2 Vokanamet combines two oral glucose-lowering medicinal products (canagliflozin and metformin) with different and complementary mechanisms of action.3 “We are delighted to extend our European footprint for Invokana and Vokanamet to provide healthcare professionals in Norway with

OnMiners Mining Rigs Offering the Biggest Hash-Rate in the Market20.3.2019 10:00:00 EETTiedote

OnMiners S.A (http://www.onminers.com) is steadily emerging as a gamechanger in the rapidly evolving global cryptocurrency market. The company recently announced its arrival with three cryptocurrency mining rigs, each offering hash rates that are unheard of in the industry. The three products from OnMiners can be used for mining Bitcoin, Litecoin, Ethereum, Monero, Dash, and Zcash. The earliest customers of the company have already started making profits in less than one month. On2U: 140 TH/s, 38 GH/s, and 5 GH/s for Bitcoin, Litecoin, and Ethereum respectively. On4U: 270 TH/s, 75 GH/s, and 9 GH/s for Bitcoin, Litecoin, and Ethereum respectively. OnTower: 1620TH/s, 450 GH/s, and 54 GH/s for Bitcoin, Litecoin, and Ethereum respectively. Hash rate has a significant impact on the profitability of crypto mining, a process that involves finding blocks through complex computations. It can be defined as the speed at which a given mining machine operates. A higher has rate is extremely favoura

HKTDC Hong Kong Houseware Fair Opens in April20.3.2019 06:17:00 EETTiedote

Asia’s leading HKTDC Hong Kong Houseware Fair is welcoming its 34th edition in the Hong Kong Convention and Exhibition Centre from 20-23 April 2019. Some 2,200 global exhibitors will showcase a wide range of high-quality household items to global buyers. In 2018, over 29,500 buyers from 112 countries and regions visited the fair. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190319005980/en/ Asia's leading houseware fair. (Photo: Business Wire) WGSN to Curate the Latest Houseware Trends HKTDC is partnering with WGSN, a well-known trend forecasting agency, to curate the trend concept display areas, unveiling the Spring/Summer 2020 houseware trends with a variety of houseware and interior design products on display. “L.I.F.E.” Theme to Showcase Quality Products In order to create an easy-to-navigate setting and provide a superior sourcing experience, the Houseware Fair will continue to feature products under four main themes

New GSMA Study: China’s Mobile Ecosystem Equivalent To 5.5% Of China’s GDP20.3.2019 06:00:00 EETTiedote

China’s mobile ecosystem added RMB5.2 trillion ($750 billion) in value to the country’s economy last year, equivalent to 5.5 per cent of China’s GDP in 20181, according to a new GSMA report. The data features in the first ever China edition of the GSMA’s Mobile Economy report series, which is published today at a special roundtable event in Beijing to discuss the latest developments in the Chinese mobile industry as it enters the 5G era. “Our new report outlines how China’s mobile industry has been a key driver of economic growth, inclusion and modernisation – creating a new generation of digital consumers and transforming industry and society,” said Mats Granryd, Director General of the GSMA. “After spending billions over the last decade deploying 4G networks to all corners of the country, Chinese mobile operators are now set to invest a further RMB401 billion ($58 billion) over the next two years to prepare for and begin 5G rollouts, laying the groundwork for China to become one of t

Rimini Street CEO Visits Seoul, Addresses Changing IT Mission20.3.2019 02:00:00 EETTiedote

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, is committed to helping South Korean companies reduce ongoing IT operating costs and freeing up significant IT budget to invest in innovation, competitive advantage and growth, co-founder and CEO Seth A. Ravin explained during a press conference in Seoul. Mr. Ravin also highlighted continued strong and growing demand in Korea for the Company’s award-winning, ultra-responsive enterprise software support model, which is disrupting the $160 billion enterprise software maintenance market worldwide. As the 4th largest economy in Asia, and the 11th largest in the world, South Korea represents a large market opportunity for the Company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190319005832/en/ Rimini Street CEO Visits Seoul,

SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer19.3.2019 23:00:00 EETTiedote

SOTIO, a biotechnology company owned by the PPF Group, presented results from SOV02, its Phase II clinical trial evaluating DCVAC/OvCa, an active cellular immunotherapy product, in patients with recurrent ovarian cancer at 2019 SGO’s 50 th Annual Meeting on Women's Cancer today. Final analysis of SOV02 shows that DCVAC/OvCa decreased the risk of death significantly compared to patients who did not receive DCVAC/OvCa. Clinical trial results were presented during today’s SGO 2019 Plenary Session by SOV02 principal investigator David Cibula, MD, PhD from General University Hospital in Prague (Czech Republic). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190319005837/en/ In the randomized, open label SOV02 clinical trial, patients with recurrent ovarian cancer received DCVAC/OvCa in combination with platinum-based chemotherapy. Compared to patients who did not receive DCVAC, it decreased the risk of death by 62%. The combinati

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme